Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

Abstract

Subtype-specific differences in HIV disease progression suggest that the local subtype distribution be considered when planning HIV programs and designing and defining clinical endpoints for HIV prevention trials.